SCHEMBL4382415

SCHEMBL4382415

CCCC(=O)OC(C)C(CCCC(=O)O)(C(=O)O)C(C)OC(=O)CCC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
LMNA P02545 3/20 0.38
AKR1B1 P15121 1/20 0.37
FFAR3 O14843 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
GPR84 Q9NQS5 7/20 0.36
PPARG P37231 7/20 0.36
PPARD Q03181 7/20 0.36
PPARA Q07869 7/20 0.36
HDAC11 Q96DB2 5/20 0.36
TSHR P16473 5/20 0.36
PTPN1 P18031 3/20 0.36
TLR2 O60603 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
FABP4 P15090 2/20 0.36
SLC22A6 Q4U2R8 1/20 0.36
SLC22A8 Q8TCC7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4388768 0.95 LMNA (0.40) ALDH1A1LMNAAKR1B1GPR84PPARG
SCHEMBL4394578 0.94 LMNA (0.42) ALDH1A1LMNAAKR1B1GPR84PPARG
SCHEMBL4382997 0.94 LMNA (0.42) ALDH1A1LMNAAKR1B1GPR84PPARG
SCHEMBL4386097 0.94 LMNA (0.42) ALDH1A1LMNAAKR1B1GPR84PPARG
SCHEMBL4384310 0.94 LMNA (0.42) ALDH1A1LMNAAKR1B1GPR84PPARG
SCHEMBL4390867 0.94 LMNA (0.42) ALDH1A1LMNAAKR1B1GPR84PPARG
SCHEMBL8195702 0.90 FFAR3 (0.39) ALDH1A1LMNAAKR1B1FFAR3HDAC3
SCHEMBL4382359 0.90 LMNA (0.53) ALDH1A1LMNAAKR1B1GPR84PPARG
SCHEMBL4383481 0.89 TSHR (0.35) ALDH1A1LMNAAKR1B1GPR84PPARG
SCHEMBL4385701 0.87 LMNA (0.53) ALDH1A1LMNAAKR1B1GPR84PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7629383-B2 Double esters DRUG DISCOVERY LABORATORY AS (NO) 2009-12-08 US disclosed
US-20050203181-A1 Double esters DRUG DISCOVERY LABORATORY AS (NO) 2005-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050203181-A1 Double esters ACACA, CES1, ACACB ALDH1A1 296/4885LMNA 1955/4885AKR1B1 512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.